Cargando…
Paving the way to precision medicine for diabetic kidney disease: the PRIORITY trial
Autores principales: | Schechter, Meir, Leibowitz, Gil, Mosenzon, Ofri |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812219/ https://www.ncbi.nlm.nih.gov/pubmed/33490210 http://dx.doi.org/10.21037/atm-2020-117 |
Ejemplares similares
-
In Vivo Biomarker Imaging: Paving the Way for Precision Medicine
por: Liu, Guanshu, et al.
Publicado: (2023) -
Preventing all‐cause hospitalizations in type 2 diabetes with sodium‐glucose cotransporter‐2 inhibitors and glucagon‐like peptide‐1 receptor agonists: A narrative review and proposed clinical approach
por: Schechter, Meir, et al.
Publicado: (2022) -
Commentary: Paving the way with visualization of the invisible craftsmanship
por: Nakamura, Shota, et al.
Publicado: (2021) -
Together or not together: Paving the way to boundary crossing
por: van Duin, Titia S., et al.
Publicado: (2022) -
Paving a way to treat spastic paraplegia 50
por: Brent, Jonathan R., et al.
Publicado: (2023)